Rob Dillard

DocwireNews

<h2><a href="https://www.docwirenews.com/vte-knowledge-hub/vte-knowledge-hub-picks/long-term-risk-of-major-bleeding-after-discontinuing-anticoagulation-for-unprovoked-venous-thromboembolism-a-systematic-review-and-meta-analysis-4/">VTE Patients have a Risk of Major Bleeding Once Anticoagulants are Discontinued</a><p>Currently, the long-term risk of major bleeding after discontinuing anticoagulant therapy for a first unprovoked venous thromboembolism (VTE) is uncertain. A study published in <em>Thrombosis and Haemostasis</em> sought to discern the incidence of major bleeding up to 5 years after discontinuing anticoagulation for a first unprovoked VTE.</p><p>To conduct this analysis, the investigators searched MEDLINE, EMBASE, and Cochrane CENTRAL from inception to January 2021 to identify relevant randomized controlled trials (RCTs) and prospective cohort studies reporting major bleeding after discontinuing anticoagulation in patients with a first unprovoked VTE who had completed at least three months of initial treatment. In total, the analysis consisted of 20 studies (17 RCTs), and 8,740 patients.</p><p><b>&ldquo;</b>Patients with a first unprovoked VTE have a non-trivial risk of major bleeding once anticoagulants are discontinued,&rdquo; the researchers concluded. &ldquo;Estimates from this study can help clinicians counsel patients about the incremental risk of major bleeding with extended anticoagulation to guide decision making about treatment duration for unprovoked VTE.&rdquo;</p><h2><a href="https://www.docwirenews.com/pad-knowledge-hub/pad-knowledge-hub-picks/analyzing-the-dose-response-relationship-between-physical-activity-and-pad/">Analyzing the Dose-Response Relationship Between Physical Activity and PAD</a></h2><p>A study found that the prevalence of peripheral artery disease (PAD) is inversely associated with physical activity (PA). The results appeared in <em>Frontiers in Cardiovascular Medicine.</em></p><p>This study assessed 1,370 adults aged 40 years and older who had participated in the National Health and Nutrition Examination Survey (NHANES) from 1999-2004. The ABI of the participants were measured, and PAD was defined as ABI &#8806;0.9. PA was procured via a standard questionnaire, and metabolic equivalents (MET) were used to quantify the PA level. Logistic regression was employed to discern the link association between PA and incidence of PAD, and the dose-response relationship was analyzed with RCS.</p><h2><a href="https://www.docwirenews.com/cardiology/assessing-the-effects-of-intracranial-atherosclerosis-and-atrial-fibrillation-on-the-prognosis-of-ischemic-stroke-with-active-cancer/">Assessing the Effects of Intracranial Atherosclerosis and AFib on the Prognosis of Ischemic Stroke with Active Cancer</a></h2><p>A study found that intracranial atherosclerosis (ICAS), but not atrial fibrillation (AF), was closely associated with poor prognosis in ischemic stroke patients with active cancer. The results were published in <em>PLoS One.</em></p><p><strong class="sub-title">&ldquo;</strong>In ischemic stroke patients with active cancer, cryptogenic stroke has worse prognosis than stroke by conventional mechanisms. However, the individual effects of ICAS or AF on the prognosis of these patients have not been studied,&rdquo; the researchers wrote.</p></h2>


Jayme Locke, MD, MPH

Joel M. Topf, MD, FACP

The Promise of Xenotransplantation

NKF Spring Clinical Meetings 2025

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Sacituzimab Govitecan Showed Modest Activity for CNS Metastases

Triple-Negative Breast Cancer

Latest News

Cardio Round-Up: Assessing Dose-Response Between PAD and Physical Activity; and More

Cardiology

VTE Patients have a Risk of Major Bleeding Once Anticoagulants are Discontinued ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe